Anemia, costs and mortality in Chronic Obstructive Pulmonary Disease
Tóm tắt
Little is known about cost implications of anemia and its association with mortality in chronic obstructive pulmonary disease (COPD). This claims analysis addresses these questions.
Using the the US Medicare claims database (1997–2001), this study identified Medicare enrollees with an ICD-9 diagnosis of COPD. Concomitant anemia was identified based on ICD-9 codes or receipt of transfusions. Persons with anemia secondary to another disease state, a nutritional deficiency or a hereditary disease were excluded. Medicare claims and payments, resource utilization and mortality were compared between COPD patients with and without anemia.
Of the 132,424 enrollees with a COPD diagnosis, 21% (n = 27,932) had concomitant anemia. At baseline, anemic patients were older, had more co-morbidities and higher rates of health care resource use than non-anemic individuals with COPD. In a univariate analysis annual Medicare payments for persons with anemia were more than double for those without anemia ($1,466 vs. $649, p < 0.001), the direction maintained in all categories of payments. Adjusting for demographics, co-morbidities, and other markers of disease severity revealed that anemia was independently associated with $3,582 incremental increase per patient (95% CI: $3,299 to $3,865) in Medicare annual reimbursements. The mortality rate among COPD patients with anemia was 262 vs. 133 deaths per 1,000 person-years among those without anemia (p < 0.001).
Anemia was present in 21% of COPD patients. Although more prevalent in more severely ill COPD patients, anemia significantly and independently contributes to the costs of care for COPD and is associated with increased mortality.
Từ khóa
Tài liệu tham khảo
Pauwels RA, Rabe KF: Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004,364(9434):613–620. 10.1016/S0140-6736(04)16855-4
Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001,163(5):1256–1276.
National Heart Lung and Blood Institute: Morbidity & Mortality: 2004 Chart Book on Cardiovascular, Lung, and Blood Diseases. Bethesda, MD , National Institutes of Health; 2004.
McCullough PA, Lepor NE: The deadly triangle of anemia, renal insufficiency, and cardiovascular disease: implications for prognosis and treatment. Rev Cardiovasc Med 2005,6(1):1–10. 10.1016/j.carrev.2005.06.002
McCullough PA, Lepor NE: Piecing together the evidence on anemia: the link between chronic kidney disease and cardiovascular disease. Rev Cardiovasc Med 2005, 6 Suppl 3: S4–12.
Nissenson AR, Wade S, Goodnough T, Knight K, Dubois RW: Economic burden of anemia in an insured population. J Manag Care Pharm 2005,11(7):565–574.
Ershler WB, Chen K, Reyes EB, Dubois R: Economic burden of patients with anemia in selected diseases. Value Health 2005,8(6):629–638.
Lyman GH, Berndt ER, Kallich JD, Erder MH, Crown WH, Long SR, Lee H, Song X, Finkelstein SN: The economic burden of anemia in cancer patients receiving chemotherapy. Value Health 2005,8(2):149–156. 10.1111/j.1524-4733.2005.03089.x
Cote C, Zilberberg M, Mody S, Celli B: Anemia is a predictor of mortality in patients with COPD. Proceedings of the American Thoracic Society 2005, A890.
Cote C, Zilberberg M, Mody S, Celli B: Anemia is associated with increased breathlessness and decreased 6-minute walk distance in COPD patients. Proceedings of the American Thoracic Society 2005, A498.
Chambellan A, Chailleux E, Similowski T: Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest 2005,128(3):1201–1208. 10.1378/chest.128.3.1201
John M, Hoernig S, Doehner W, Okonko DD, Witt C, Anker SD: Anemia and inflammation in COPD. Chest 2005,127(3):825–829. 10.1378/chest.127.3.825
Yip R, Johnson C, Dallman PR: Age-related changes in laboratory values used in the diagnosis of anemia and iron deficiency. Am J Clin Nutr 1984,39(3):427–436.
World Health Organization: Iron deficiency anaemia: assessment, prevention and control. A guide for programme managers. Document WHO/NHD/01.3 . Geneva, Switzerland , World Health Organization; 2001.
Maggioni AP, Opasich C, Anand I, Barlera S, Carbonieri E, Gonzini L, Tavazzi L, Latini R, Cohn J: Anemia in patients with heart failure: prevalence and prognostic role in a controlled trial and in clinical practice. J Card Fail 2005,11(2):91–98. 10.1016/j.cardfail.2004.05.004
Locatelli F, Pozzoni P, Tentori F, del Vecchio L: Epidemiology of cardiovascular risk in patients with chronic kidney disease. Nephrol Dial Transplant 2003, 18 Suppl 7: vii2–9.
Silverberg D: Outcomes of anaemia management in renal insufficiency and cardiac disease. Nephrol Dial Transplant 2003, 18 Suppl 2: ii7–12.
Stewart ST: Do out-of-pocket health expenditures rise with age among older Americans? Gerontologist 2004,44(1):48–57.
Mapel D, Chen JC, George D, Halbert RJ: The cost of chronic obstructive pulmonary disease and its effects on managed care. Manag Care Interface 2004,17(4):61–66.
Wilchesky M, Tamblyn RM, Huang A: Validation of diagnostic codes within medical services claims. J Clin Epidemiol 2004,57(2):131–141. 10.1016/S0895-4356(03)00246-4
Zilberberg M, Pisano M: Pulmonologists' perceptions of anemia in COPD: a survey. Value Health 2005, 8: 426. 10.1111/j.1524-4733.2005.08306.x